After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed NIAID-Sponsored Study Shows N-803 Combined with Neutralizing Antibodies Could Lead to Sustained HIV Viral Control After Discontinuation of Antiretroviral Therapy.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
ImmunityBio Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of ImmunityBio Inc is $3.67B. A total of 4.43 million shares were traded on the day, compared to an average of 4.01M shares.
In the most recent transaction, BLASZYK MICHAEL D bought 71,915 shares of IBRX for 2.75 per share on Jun 05 ’23. After the transaction, the Director now owns 71,915 company shares. In a previous transaction on Jun 02 ’23, Brennan John Owen bought 25,000 shares at 2.83 per share. IBRX shares that Director owns now total 25,000.
Among the insiders who bought shares, Clark Wesley acquired of 7,000 shares on Jun 01 ’23 at a per-share price of $2.91. This resulted in the Director holding 8,000 shares of IBRX after the transaction.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, IBRX has a high of $6.93 and a low of $1.25.
As of this writing, IBRX has an earnings estimate of -$0.16 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of -$0.16 per share and a lower estimate of -$0.16. The company reported an EPS of -$0.19 in the last quarter, which was 24.00% higher than expectations of -$0.25.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. IBRX’s latest balance sheet shows that the firm has $317.12M in Cash & Short Term Investments as of fiscal 2021. There were $645.66M in debt and $369.00M in liabilities at the time. Its Book Value Per Share was -$0.87, while its Total Shareholder’s Equity was -$243.91M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IBRX is Buy with a score of 4.00.
